Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC. more
Time Frame | BLACU | Sector | S&P500 |
---|---|---|---|
1-Week Return | - | -1.63% | -0.57% |
1-Month Return | 8.58% | -0.38% | 1.21% |
3-Month Return | 8.58% | 11.39% | 7.57% |
6-Month Return | 9.48% | 21.58% | 11.45% |
1-Year Return | 12.06% | 33.28% | 28.48% |
3-Year Return | 18.9% | 28.35% | 29.52% |
Dec '20 | Dec '21 | Dec '22 | Dec '23 | |||
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Cost of Revenue | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Gross Profit | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Gross Margin | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Operating Expenses | 23.81K | 3.31K | 35.39K | 1.83M | [{"date":"2020-12-31","value":1.3,"profit":true},{"date":"2021-12-31","value":0.18,"profit":true},{"date":"2022-12-31","value":1.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Operating Income | (23.81K) | (3.31K) | (35.39K) | (1.83M) | [{"date":"2020-12-31","value":-2381000,"profit":false},{"date":"2021-12-31","value":-330800,"profit":false},{"date":"2022-12-31","value":-3538800,"profit":false},{"date":"2023-12-31","value":-183070000,"profit":false}] | |
Total Non-Operating Income/Expense | - | - | 2.00 | 5.55M | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Pre-Tax Income | (23.81K) | (3.31K) | (35.39K) | 944.59K | [{"date":"2020-12-31","value":-2.52,"profit":false},{"date":"2021-12-31","value":-0.35,"profit":false},{"date":"2022-12-31","value":-3.75,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] | |
Income Taxes | (206.30K) | (236.56K) | (228.48K) | 540.81K | [{"date":"2020-12-31","value":-38.15,"profit":false},{"date":"2021-12-31","value":-43.74,"profit":false},{"date":"2022-12-31","value":-42.25,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] | |
Income After Taxes | - | - | 193.09K | 403.78K | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":47.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Income From Continuous Operations | - | (3.31K) | (35.39K) | 403.78K | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.82,"profit":false},{"date":"2022-12-31","value":-8.76,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] | |
Income From Discontinued Operations | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Net Income | (23.81K) | (3.31K) | (35.39K) | 403.78K | [{"date":"2020-12-31","value":-5.9,"profit":false},{"date":"2021-12-31","value":-0.82,"profit":false},{"date":"2022-12-31","value":-8.76,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] | |
EPS (Diluted) | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
These ratios help you determine the liquidity of the company. Higher is better.
BLACU | |
---|---|
Cash Ratio | 0.00 |
Current Ratio | 0.01 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BLACU | |
---|---|
ROA (LTM) | -2.98% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BLACU | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.29 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.71 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BLACU | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.00 |
EV/R | 0.00 |
EV/Ebitda | NM |
Bellevue Life Sciences Acquisition Corp. Unit (BLACU) share price today is $11.89
Yes, Indians can buy shares of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) on Vested. To buy Bellevue Life Sciences Acquisition Corp. Unit from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BLACU stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) via the Vested app. You can start investing in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) with a minimum investment of $1.
You can invest in shares of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) via Vested in three simple steps:
The 52-week high price of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) is $12. The 52-week low price of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) is $10.6.
The price-to-earnings (P/E) ratio of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) is
The price-to-book (P/B) ratio of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) is 0.00
The dividend yield of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) is 0.00%
The market capitalization of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) is
The stock symbol (or ticker) of Bellevue Life Sciences Acquisition Corp. Unit is BLACU